Sheliang Shen Selected Research

Cadherins (E-Cadherin)

1/2018

Propofol Reversed Hypoxia-Induced Docetaxel Resistance in Prostate Cancer Cells by Preventing Epithelial-Mesenchymal Transition by Inhibiting Hypoxia-Inducible Factor 1α.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sheliang Shen Research Topics

Disease

2	Hemorrhage 01/2016 - 01/2015
1	Pain (Aches) 06/2018
1	Hypoxia (Hypoxemia) 01/2018
1	Prostatic Neoplasms (Prostate Cancer) 01/2018
1	Coronary Disease (Coronary Heart Disease) 08/2017

Drug/Important Bio-Agent (IBA)

2	Propofol (Diprivan)FDA LinkGeneric 01/2018 - 08/2017
2	Heparin (Liquaemin)FDA LinkGeneric 01/2016 - 01/2015
1	Cytochrome P-450 CYP3AIBA 06/2018
1	Fentanyl (Sublimaze)FDA LinkGeneric 06/2018
1	Pharmaceutical PreparationsIBA 01/2018
1	Small Interfering RNA (siRNA)IBA 01/2018
1	Docetaxel (Taxotere)FDA Link 01/2018
1	Cadherins (E-Cadherin)IBA 01/2018
1	5-ethynyl-2'-deoxyuridineIBA 01/2018
1	VimentinIBA 01/2018
1	Remifentanil (Ultiva)FDA Link 08/2017
1	Sevoflurane (Ultane)FDA LinkGeneric 08/2017

Therapy/Procedure

2	Cardiopulmonary Bypass (Heart-Lung Bypass) 01/2016 - 01/2015